Figure 3
Figure 3. Comparison of fractions of T cells and NK (CD56+) cells from healthy EBV-seropositive patients who respond to autologous LCL. (A) Dotplot depiction of IFNγ-producing cells after application of gates on CD8+, CD4+, and γ-δ TCR+ cells. The percentages in the right upper quadrants indicate the fraction of the cell type that produced IFNγ. (B) Larger fractions of circulating γ-δ T cells, and NK cells than those of circulating CD8+ and CD4+ T cells respond to autologous LCL in healthy EBV-seropositive patients.

Comparison of fractions of T cells and NK (CD56+) cells from healthy EBV-seropositive patients who respond to autologous LCL. (A) Dotplot depiction of IFNγ-producing cells after application of gates on CD8+, CD4+, and γ-δ TCR+ cells. The percentages in the right upper quadrants indicate the fraction of the cell type that produced IFNγ. (B) Larger fractions of circulating γ-δ T cells, and NK cells than those of circulating CD8+ and CD4+ T cells respond to autologous LCL in healthy EBV-seropositive patients.

Close Modal

or Create an Account

Close Modal
Close Modal